Ilex Medical

Ilex Medical Interest Coverage

The Interest Coverage Ratio of Ilex Medical (ILX.TA) as of Oct 23, 2026 is 9.89. In the previous year, Interest Coverage Ratio was 42.08 — a change of -76.49% (lower).

Interest Coverage

9.89

YoY

-76.49%

Last updated:

Interest Coverage Ratio of Ilex Medical is 2024 9.89 . Interest Coverage Ratio of Ilex Medical was 2023 42.08 . It decreases by -76.49% lower compared to the previous year.

The Ilex Medical Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
8.70 ILS
Jan 1, 2018
11.73 ILS
Jan 1, 2019
12.38 ILS
Jan 1, 2020
17.43 ILS
Jan 1, 2021
39.91 ILS
Jan 1, 2022
32.86 ILS
Jan 1, 2023
42.08 ILS
Jan 1, 2024
9.89 ILS
The Ilex Medical Interest Coverage history
YEARInterest CoverageYoY
9.89-76.49%
42.08+28.06%
32.86-17.66%
39.91+128.96%
17.43+40.80%
12.38+5.52%
11.73+34.81%
8.70-44.49%
15.68-79.65%
77.04+1,106.62%
6.38—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ilex Medical Stock analysis

What does Ilex Medical do? Ilex Medical Ltd supplies in vitro diagnostic equipment and laboratory management software, targeting healthcare providers and laboratories. The company offers nucleic acid testing (NAT) blood screening solutions, cancer screening products, retro virus load monitoring, TB and STD testing systems, and blood sugar monitoring devices. Its subsidiaries include Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd, and Medtechnica Ltd, which support its diagnostic equipment and software distribution. Healthcare facilities and diagnostic laboratories purchase these products for clinical testing and patient management. Ilex Medical Ltd's revenue streams come from selling diagnostic equipment, reagent systems, and laboratory information systems (LIS) to healthcare institutions. The firm's NAT blood screening solutions and infectious disease testing systems are key products for blood banks and public health labs. Subsidiaries like Orsyx-LIS provide specialized laboratory management software, enhancing the company's offerings in the diagnostic software segment. Hospitals and clinics rely on these solutions for efficient diagnostic workflows. The company serves segments including hospitals, blood banks, public health laboratories, and clinics focused on infectious disease management. Products such as cancer screening tools and retro virus load systems are sold to specialized medical facilities. Ilex South Africa and Medtechnica Ltd extend the company's reach in regional markets, supporting localized sales and service. Diagnostic software from Orsyx-LIS is integrated into laboratory workflows for improved data management. Ilex Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilex Medical stock

Interest Coverage Ratio of Ilex Medical is 9.89 in 2024.

Interest Coverage Ratio of Ilex Medical changed from 42.08 to 9.89, representing a -76.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Ilex Medical since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Ilex Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Ilex Medical

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Ilex Medical